首页> 外文期刊>Medical science monitor : >Effects of Bretschneider cardioplegic fluid on the lysosomal cathepsins D and L of myocardium of coronary patients during coronary-aortal bypass graft operation
【24h】

Effects of Bretschneider cardioplegic fluid on the lysosomal cathepsins D and L of myocardium of coronary patients during coronary-aortal bypass graft operation

机译:Bretschneider心脏停搏液对冠脉搭桥术中冠状动脉患者溶酶体组织蛋白酶D和L的影响

获取原文
           

摘要

We evaluated the effects of replacing the standard St. Thomas Hospital (ST) cardioplegic fluid with Bretschneider (BR) fluid during coronary-aortal bypass graft operation (CABG) in patients with coronary disease. BR fluid contains enormous concentration of histidine (~ 0.2 mole L-1): thus increased levels of histamine or other metabolites might exert some cardiovascular effects. Therefore, the changes in the level of two lysosomal proteases: cathepsin D and L of myocardium were evaluated. Small fragments of right atrium (SFRA) were taken out during CABG: just before the injection of cold cardioplegia (control), at the peak of ischaemia and after reperfusion. Cathepsin D and L were assayed in SFRA homogenates at pH 3.6 (with haemoglobin as a substrate and pepstatin as cathepsin D inhibitor). The values of parameters Ai and Ae: being the indexes of intralysosomal (Ai) and extralysosomal (Ae) activation or inactivation of cathepsins were calculated.Results/Conclusions: With BR cardioplegia - unlikely ST fluid - there is a significant increase in total activity (T) of both cathepsins but free (F) only for cathepsin L during ischaemia with come back (to the control level) during reperfusion period. T for both cathepsins and F for cathepsin L with BR are much greater than those with ST fluid both in ischaemia and reperfusion period. BR cardioplegia results in distinct, extralysosomal activation of cathepsin L during ischaemia instead of the inhibition found with ST fluid.
机译:我们评估了在患有冠心病的患者进行冠脉搭桥术(CABG)期间,用Bretschneider(BR)液替代标准的St. Thomas医院(ST)心脏停搏液的效果。 BR液中含有大量的组氨酸(约0.2摩尔L-1):因此,增加组胺或其他代谢物的含量可能会产生一些心血管作用。因此,评估了两种溶酶体蛋白酶的水平的变化:心肌的组织蛋白酶D和L。在CABG期间取出右心房小碎片(SFRA):在注射冷心麻痹之前(对照),局部缺血高峰和再灌注后。在pH 3.6的SFRA匀浆中测定组织蛋白酶D和L(血红蛋白为底物,胃蛋白酶抑制素为组织蛋白酶D抑制剂)。计算参数Ai和Ae的值:是组织蛋白酶的溶酶体内(Ai)和溶酶体外(Ae)活化或失活的指标。结果/结论:BR心脏麻痹-ST液不太可能-总活性显着增加(两种组织蛋白酶的T)值,但缺血时仅组织蛋白酶L的游离(F)值,而在再灌注期间又恢复(至对照水平)。在缺血和再灌注期间,具有BR的组织蛋白酶的T值和具有L的组织蛋白酶L的F值均远大于具有ST液的组织蛋白酶。 BR心脏麻痹可导致局部缺血期间组织蛋白酶L的明显的,体外激活,而不是ST液的抑制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号